Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
22,954,586
-
Shares change
-
+7,707,122
-
Total reported value, excl. options
-
$600,024,825
-
Value change
-
+$219,416,366
-
Number of buys
-
49
-
Number of sells
-
-22
-
Price
-
$26.14
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q1 2014
76 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q1 2014.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22,954,586 shares
of 80,437,135 outstanding shares and own 28.5% of the company stock.
Largest 10 shareholders include FMR LLC (4,511,515 shares), BROOKSIDE CAPITAL MANAGEMENT LLC (2,862,025 shares), CREDIT SUISSE AG/ (2,268,899 shares), WELLINGTON MANAGEMENT CO LLP (1,457,157 shares), RA CAPITAL MANAGEMENT, LLC (981,761 shares), Sectoral Asset Management Inc (947,902 shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (901,423 shares), JENNISON ASSOCIATES LLC (861,826 shares), ORBIMED ADVISORS LLC (830,100 shares), and State Street Corp (693,456 shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.